Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:2
Phase 4:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 4
1 (33.3%)FREEDOM COVID-19 Anticoagulation Strategy
- First Posted Date
- 2020-08-13
- Last Posted Date
- 2023-03-16
- Lead Sponsor
- Valentin Fuster
- Target Recruit Count
- 3460
- Registration Number
- NCT04512079
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
🇧🇷Instituto do Coração - INCOR, São Paulo, Brazil
🇧🇷Instituto Prevent Senior - IPS, São Paulo, Brazil
Promoting Heart Health in Preschool Children
Phase 3
Completed
- Conditions
- Cardiovascular Health
- First Posted Date
- 2012-03-12
- Last Posted Date
- 2017-01-09
- Lead Sponsor
- Valentin Fuster
- Target Recruit Count
- 2279
- Registration Number
- NCT01551355
- Locations
- 🇨🇴
Fundación CardioInfantil Instituto de Cardiología, Bogota, Colombia
Comparison of Two Treatments for Multivessel Coronary Artery Disease in Individuals With Diabetes (FREEDOM)
Phase 3
- Conditions
- Coronary DiseaseHeart DiseasesCardiovascular DiseasesDiabetes Mellitus
- First Posted Date
- 2004-07-05
- Last Posted Date
- 2017-02-06
- Lead Sponsor
- Valentin Fuster
- Target Recruit Count
- 1900
- Registration Number
- NCT00086450
- Locations
- 🇺🇸
Icahn School of Medicine at Mount Sinai, New York, New York, United States
News
No news found